Congressional Research Service Reports - Browse

ABOUT BROWSE FEED
Marijuana: Medical and Retail -- An Abbreviated View of Selected Legal Issues
This report discusses the federal law regarding marijuana that is classified as a Schedule I Controlled Substance. The federal Controlled Substances Act (CSA) outlaws the possession, cultivation, or distribution of marijuana except for authorized research.
Marijuana: Medical and Retail -- Selected Legal Issues
This report discusses state medical marijuana laws that grants registered patients, their doctors, and providers immunity from the consequences of state law.
Marijuana: Medical and Retail-- Selected Legal Issues
This report discusses the federal Controlled Substances Act (CSA) as it pertains to marijuana. The CSA outlaws the possession, cultivation, and distribution of marijuana except for authorized research. More than 20 states have regulatory schemes that allow possession, cultivation, and distribution of marijuana for medicinal purposes. The U.S. Constitution's Supremacy Clause preempts any state law that conflicts with federal law.
Active Opioid Legislation in the House: In Brief
This report briefly summarizes opioid-related bills that were considered during "Opioid Week" (the week of May 9, 2016) The summaries in this report may be useful illustrations of the range of approaches Members of Congress have proposed to address the problem of opioid addiction.
No-fault Eviction of Public Housing Tenants for Illegal Drug Use: A Legal Analysis of Department of Housing and Urban Development v. Rucker
No Description Available.
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
This report provides an overview of the Fourth Amendment in order to effectively evaluate the constitutionality of laws requiring suspicionless drug tests to receive governmental benefits. It then reviews five Supreme Court decisions that have evaluated these programs. The report concludes with a synthesis of the various factors that likely will be important to a future court's assessment of the constitutionality of these laws.
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
Methamphetamine: Legislation and Issues in the 109th Congress
This report provides a brief overview of illicit methamphetamine (MA) abuse, production, trafficking, the federal methamphetamine-specific programs, and anti-MA legislation introduced in the 109th Congress. MA abuse has implications for public health, child welfare, crime and public safety, border security, and international relations.
2016 Rio Games: Anti-Doping Testing
This report discusses the the anti-doping testing program during the 2016 Summer Olympics. Responsibility for the rests with the International Olympic Committee (IOC). The testing period began July 24, 2016, when the Olympic village opened, and continues through August 21, 2016, the date of the closing ceremony.
Methamphetamine: Legislation and Issues in the 109th Congress
No Description Available.
Smokeless Tobacco: Snuff and Chewing Tobacco; Bibliography-in-Brief, 1983-1987
No Description Available.
Smokeless Tobacco: Snuff and Chewing Tobacco; Bibliography-in-Brief, 1983-1987
No Description Available.
War on Drugs: The National Youth Anti-Drug Media Campaign
This report discusses the authorization of the National Youth Anti-Drug Media Campaign, a multi-media federal program to persuade America's youth not to use drugs, which expired at the end of FY2002. H.R. 2829 (passed by the House on March 13, 2006) and S. 2560 (reported by the Senate Judiciary Committee on May 25, 2006) would reauthorize the media campaign, along with the other programs run by the Office of National Drug Control Policy (ONDCP) during FY2007.
War on Drugs: The National Youth Anti-Drug Media Campaign
No Description Available.
War on Drugs: The National Youth Anti-Drug Media Campaign
No Description Available.
Prescription Drug Monitoring Programs
This report looks at ways that prescription drug monitoring programs (PDMPs), which maintain statewide electronic databases of prescriptions dispensed for controlled substances, can help to deter prescription drug misuse.
Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance
Report that describes and compares the drug- and crime-related policy restrictions contained in selected federal programs that provide assistance to low-income individuals and families: the Temporary Assistance for Needy Families (TANF) block grant, the Supplemental Nutrition Assistance Program (SNAP, formerly Food Stamps), and the three primary federal housing assistance programs (the public housing program, the Section 8 Housing Choice Voucher program, and the project-based Section 8 rental assistance program).
Legal Issues Relating to the Disposal of Dispensed Controlled Substances
This report describes an issue that is the fastest-growing drug problem in the country -- the intentional use of prescription drugs for non-medical purposes. It is the second-most common form of illicit drug abuse among teenagers in the United States behind marijuana use. Several bills have been introduced in the 111th Congress that would create a legal framework governing disposal of controlled substances that have been dispensed to patients.
Legal Issues Relating to the Disposal of Dispensed Controlled Substances
Prescription drug abuse is the second-most common form of illicit drug abuse among teenagers in the United States, trailing only marijuana use. Prescription drug abuse has become a particular concern amongst federal policymakers. This report discusses this issue, including related pieces of legislation such as the Controlled Substances Act, the Secure and Responsible Drug Disposal Act of 2010, and the proper way to dispose of controlled substances.
Reauthorizing the Office of National Drug Control Policy: Issues for Consideration
Report discussing the National Drug Control Strategy, the National Drug Control Budget, and the Office of National Drug Control Policy's (ONDCP) evaluation of the National Drug Control Strategy implementation. It also provides an analysis of selected legislative and oversight issues that Congress may consider when debating the reauthorization of ONDCP.
Prescription Drug Monitoring Programs
This report looks at ways that prescription drug monitoring programs (PDMPs), which maintain statewide electronic databases of prescriptions dispensed for controlled substances, can help to deter prescription drug misuse.
Federal Laws Relating to the Control of Narcotics and Other Dangerous Drugs, Enacted 1961-1985: Brief Summaries
This report contains summaries of enactments, treaties, and reorganization plans, passed from 1961 through 1985, that have some clearly indicated relationship-- either by specific reference or by virtue of legislative history--to the Federal effort to prevent drug misuse through control of the supply of narcotics and other dangerous drugs.
Heroin: Legalization for Medical Use
This report discusses the limited legalization of diacetylmorphine (heroin) for use in the medical treatment of intractable pain. The report attempts to present pros and cons on the issue as well as information on pending legislation. The report also provides a comparison of heroin's analgesic qualities to those of currently available and equivalent pharmaceutical alternatives.
The World Drug Problem: UNGA Convenes for a Special Session
This report briefly discusses the United Nations General Assembly's (UNGA) 2016 special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues.
War on Drugs: Reauthorization of the Office of National Drug Control Policy
This report discusses the Office of National Drug Control Policy Reauthorization Act of 2005 , which would reauthorize ONDCP for five years, through FY2010, and authorize funding in specific annual amounts for the High Intensity Drug Trafficking Area (HIDTA) Program, the media campaign, a Southwest Border violence study, and several anti-methamphetamine initiatives.
Narcotics Certification of Drug Producing Trafficking Nations: Questions and Answers
No Description Available.
Taliban and the Drug Trade
No Description Available.
Federal Drug Control: President's Budget Request for Fiscal Year 1988
This report discusses the President's FY1988 budget, focusing on the $3 billion set aside for Federal programs to control or prevent the use of narcotics and other dangerous drugs. The report includes various key documents illustrating the positions taken by Congressional critics of the request as well as the Administration's defenses. Finally, for a longer term perspective, there are graphs and a table showing drug budget trends since FY 1981.
Federal Drug Control: President's Budget Request for Fiscal Year 1988
This report discusses the President's FY1988 budget, focusing on the $3 billion set aside for Federal programs to control or prevent the use of narcotics and other dangerous drugs. The report includes various key documents illustrating the positions taken by Congressional critics of the request as well as the Administration's defenses. Finally, for a longer term perspective, there are graphs and a table showing drug budget trends since FY 1981.
Federal Cocaine Sentencing Disparity: Sentencing Guidelines, Jurisprudence, and Legislation
This report discusses legislation and several court cases to examine the changing nature of Crack Cocaine penalties in comparison to powder cocaine. Until 2005, the Guidelines were binding on federal courts: the judge had discretion to sentence a defendant, but only within the narrow sentencing range that the Guidelines provided. In its 2005 opinion United States v. Booker, the Supreme Court declared that the Guidelines must be considered advisory rather than mandatory, in order to comply with the Constitution. Instead of being bound by the Guidelines, sentencing courts must treat the federal guidelines as just one of a number of sentencing factors (which include the need to avoid undue sentencing disparity).
Drug Offenses: Maximum Fines and Terms of Imprisonment for Violation of the Federal Controlled Substances Act and Related Laws
This report is a chart of the maximum fines and terms of imprisonment that may be imposed as a consequence of conviction for violation of the federal Controlled Substances Act (CSA) and other drug supply and drug demand related laws.
Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance
This report describes and compares the drug- and crime-related policy restrictions contained in selected federal programs that provide assistance to low-income individuals and families: the Temporary Assistance for Needy Families (TANF) block grant, the Supplemental Nutrition Assistance Program (SNAP, formerly Food Stamps), and the three primary federal housing assistance programs (the public housing program, the Section 8 Housing Choice Voucher program, and the project-based Section 8 rental assistance program).
International Drug Control Policy
This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to current initiatives and raises several counterdrug policy issues and considerations for policy makers.
Drug Offenses: Maximum Fines and Terms of Imprisonment for Violation of the Federal Controlled Substances Act and Related Laws
This is a chart of the maximum fines and terms of imprisonment that may be imposed as a consequence of conviction for violation of the federal Controlled Substances Act (CSA) and other drug supply and drug demand related laws. It lists the penalties for: heroin, cocaine, crack, PCP, LSD, marihuana (marijuana), amphetamine, methamphetamine, listed (precursor) chemicals, paraphernalia, date rape drugs, rave drugs, designer drugs, ecstasy, drug kingpins, as well as the other substances including narcotics and opiates assigned to Schedule I, Schedule II, Schedule III, Schedule IV, and Schedule V of the Controlled Substances Act and the Controlled Substances Import and Export Act (Title II and Title III of the Comprehensive Drug Abuse and Control Act).
International Drug Control Policy
This report discusses the scope of the international drug control problem, current measures in place. It includes sections that discuss: the global scope of the problem, strategic guidance, overall U.S. drug control funding, U.S. assistance for international counternarcotics programs, policy issues, and conclusions.
Drug Certification of Mexico in 1999: Arguments For and Against Congressional Resolutions of Disapproval
This report presents arguments for and against congressional resolutions to disapprove President Clinton’s February 26, 1999 certification of Mexico as a fully cooperative country in efforts to control illicit narcotics.1 These resolutions (H.J.Res. 35--Bachus, and H.J.Res. 43--Mica and Gilman) would disapprove the President’s certification, but would permit him to avoid withholding of assistance to Mexico if he determined that vital national interests required such assistance.
Drug Certification Requirements and Congressional Modifications in 2001
This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Congressional Modifications in 2001-2002
This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Congressional Modifications in 2001-2002
This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Proposed Congressional Modifications in 2001
This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
International Drug Control Policy
This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to current initiatives and raises several counterdrug policy issues and considerations for policy makers.
War On Drugs: Legislation in the 108th Congress and Related Developments
This report covers significant legislative and oversight activities of the 108th Congress that concern domestic law enforcement aspects of federal anti-drug policy. It also includes an overview of significant executive branch actions and other current developments of likely interest to the congressional audience that follows this issue.
Drug Control: International Policy and Approaches
This report discusses various U.S. international narcotics policy approaches meant to achieve two main goals: to reduce the supply of illicit narcotics flowing into the United States, and to reduce the amount of illicit narcotics cultivated, processed, and consumed worldwide.
The World Drug Problem: UNGA Convenes for a Special Session
This report briefly discusses the United Nations General Assembly (UNGA), which has convened in New York for a special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues. Previous special sessions on drugs were held in 1990 and 1998.
The Comprehensive Addiction and Recovery Act of 2016 (S. 524): Comparison of Senate- and House-Passed Versions
This report discusses selected differences and similarities between the Senate- and House-passed versions of the Comprehensive Addiction and Recovery Act of 2016 (CARA; S. 524), which aims to address the problem of opioid addiction in the United States. The two versions of the bill differ substantially. The scope of the differences may be illustrated by their structures: The Senate bill has 28 sections organized in 8 titles, whereas the House bill has 69 sections organized in 18 titles.
International Drug Control Policy
This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to current initiatives and raises several counterdrug policy issues and considerations for policy makers.
Actions of the Congress and the Federal Government on Smoking and Health
This paper is a history of actions taken by the U.S. Congress and by the various departments and regulatory agencies of the Federal Government on the subject of smoking and health for the period from the mid-1950s to the end of the 95th Congress in 1978.
Veterans and Smoking-Related Illnesses: Congress Enacts Limits to Compensation
No Description Available.
War on Drugs: Legislation in the 108th Congress and Related Developments
No Description Available.